Carcinoid Tumor

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,

Recruiting
  • Carcinoid Syndrome
  • +8 more
  • Randomized: 40 mg Paltusotine
  • Randomized: 80 mg Paltusotine
  • Newport Beach, California
  • +5 more
Jan 3, 2023

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib

Recruiting
  • Atypical Carcinoid Tumor
  • +18 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +425 more
Aug 12, 2022

Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

Active, not recruiting
  • Carcinoid Tumor
  • Pancreatic Neuroendocrine Tumor
  • Boston, Massachusetts
  • +1 more
Jul 15, 2022

Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

Recruiting
  • Carcinoid Syndrome
  • +3 more
  • Dual-Energy Computed Tomography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2021

Dynamic Whole Body Positron Emission Tomography/Computed

Recruiting
  • Neuroendocrine Tumors
  • +5 more
  • 18F-FDG PET/CT
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Jan 25, 2021

Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)

Completed
  • Carcinoid Tumor
  • Acromegaly
  • Los Angeles, California
  • +16 more
Dec 17, 2020

Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor Trial (Lutathera)

Not yet recruiting
  • Carcinoid Heart Disease
  • +2 more
  • (no location specified)
Aug 3, 2020

Neuroendocrine Tumors, Carcinoid Tumor, Carcinoma, Neuroendocrine Trial in Quebec City (177Lu-Octreotate)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Quebec City, Quebec, Canada
    CHU de Québec - Université Laval
Jul 15, 2020

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

Recruiting
  • Neuroendocrine Tumors
  • Carcinoid Tumor
    • Aarau, Switzerland
    • +54 more
    Jan 20, 2020

    Endoscopic Treatment of Bronchial Carcinoid Tumors

    Completed
    • Carcinoid Tumor
    • Medical data collection
    • Saint-Étienne, France
      CHU de Saint-Etienne
    Oct 26, 2018

    Carcinoid Tumor Trial in San Francisco, Tampa (Axitinib)

    Completed
    • Carcinoid Tumor
    • San Francisco, California
    • +1 more
    Sep 4, 2018

    Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Tampa, Boston (AMG 479)

    Completed
    • Neuroendocrine Tumor
    • +2 more
    • AMG 479
    • Tampa, Florida
    • +2 more
    Feb 7, 2018

    Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (SOM230, RAD001)

    Completed
    • Neuroendocrine Tumor
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Oct 18, 2016

    Carcinoid Tumor, Malignant Carcinoid Syndrome Trial in Worldwide (Octreotide, Placebo, Everolimus)

    Completed
    • Carcinoid Tumor
    • Malignant Carcinoid Syndrome
    • Tucson, Arizona
    • +69 more
    Nov 11, 2014

    Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Sorafenib, RAD001)

    Completed
    • Neuroendocrine Tumor
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Apr 27, 2014

    Neuroendocrine, Neuroendocrine Tumor, Neuroendocrine Cancer Trial in Kenner (68Ga-DOTATATE will be given in tracer doses and

    Unknown status
    • Neuroendocrine
    • +7 more
    • 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.
    • Kenner, Louisiana
      Ochsner Medical Center - Kenner
    Jan 16, 2014